NeurMedix, Inc.
6165 Greenwich Drive, Suite 150
San Diego, California 92122
July 12, 2018
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 3561
Washington, D.C. 20549
Attn: Office of Healthcare and Insurance
Re: | NeurMedix, Inc. |
| Offering Statement on Form 1-A filed May 2, 2017 | |
| Amendment 1 to Offering Statement on Form 1-A filed July 17, 2017 | |
| Amendment 2 to Offering Statement on Form 1-A filed October 2, 2017 | |
| Amendment 3 to Offering Statement on Form 1-A filed February 1, 2018 | |
| Amendment 4 to Offering Statement on Form 1-A filed March 12, 2018 | |
| Amendment 5 to Offering Statement on Form 1-A filed June 11, 2018 | |
| Amendment 6 to Offering Statement on Form 1-A filed July 5, 2018 |
Dear Ms. Paik:
Having been advised by counsel that the staff of the U.S. Securities and Exchange Commission (the “Commission”) has no further comments on the above-referenced Offering Statement, on behalf of NeurMedix, Inc., we respectfully request that the Commission qualify the Form 1-A Offering Circular on Monday, July 16, 2018.
We thank the Commission staff in advance.
| Sincerely, |
|
|
| /s/ Terren S. Peizer |
|
|
| Terren S. Peizer |
cc: | CKR Law, LLP |
